RACHEL STEVENSON: Open Payments
NPI 1306026216 · GREENSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 14 payments from 10 companies in 2025. Trend: 2023 $284 · 2024 $12,640 · 2025 $858
Consulting: $450Food & beverage: $330Education: $78
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $450 |
| Gilead Sciences, Inc. | 3 | $124 |
| JAZZ PHARMACEUTICALS INC. | 1 | $115 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| PFIZER INC. | 2 | $33 |
| Astellas Pharma US Inc | 1 | $20 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $20 |
| Pharmacosmos Therapeutics Inc. | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $18 |
| Caris MPI, Inc. | 1 | $14 |
Products named: VERZENIO, Trodelvy, ZIIHERA, KISQALI, PADCEV, Vyloy, NERLYNX, MONOFERRIC.
Industry payments across PA — which companies pay providers there.
